|
|
||||||||







* Department of Basic Medical Sciences,
Department of Microbiology and Immunology,
Department of Medical Technology, and
Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, Taiwan; and
¶ Center for Disease Control, Department of Health, Taipei, Taiwan, Republic of China
Using flow cytometric assay and monoclonal anti-dengue Ab, we observed that both anti-E and anti-prM Abs could enhance dengue virus infection in a concentration-dependent but serotype-independent manner. Increases were found in both the percentage of dengue-infected cells and the expression of dengue E and NS1 protein per cell. Dengue virion binding and infection were enhanced on FcR-bearing cells via the Fc-Fc
RII pathway. Furthermore, anti-prM Ab also enhanced dengue virion binding and infection on cells lacking FcR, such as BHK-21 or A549 cells, by the mechanism of peptide (CPFLKQNEPEDIDCW)-specific binding. Anti-prM Ab cross-reacted with BHK-21 or A549 cells and recognized self-Ags such as heat shock protein 60. In summary, a novel mechanism of anti-prM Ab-mediated enhancement on dengue virus infection was found to be mediated by dual specific binding to dengue virion and to target cells, in addition to the traditional enhancement on FcR-bearing cells.
This article has been cited by other articles:
![]() |
M.-C. Chen, C.-F. Lin, H.-Y. Lei, S.-C. Lin, H.-S. Liu, T.-M. Yeh, R. Anderson, and Y.-S. Lin Deletion of the C-Terminal Region of Dengue Virus Nonstructural Protein 1 (NS1) Abolishes Anti-NS1-Mediated Platelet Dysfunction and Bleeding Tendency J. Immunol., August 1, 2009; 183(3): 1797 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Cheng, C.-F. Lin, H.-Y. Lei, H.-S. Liu, T.-M. Yeh, Y.-H. Luo, and Y.-S. Lin Proteomic Analysis of Endothelial Cell Autoantigens Recognized by Anti-Dengue Virus Nonstructural Protein 1 Antibodies Experimental Biology and Medicine, January 1, 2009; 234(1): 63 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Zybert, H. van der Ende-Metselaar, J. Wilschut, and J. M. Smit Functional importance of dengue virus maturation: infectious properties of immature virions J. Gen. Virol., December 1, 2008; 89(12): 3047 - 3051. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Junjhon, M. Lausumpao, S. Supasa, S. Noisakran, A. Songjaeng, P. Saraithong, K. Chaichoun, U. Utaipat, P. Keelapang, A. Kanjanahaluethai, et al. Differential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M Junction J. Virol., November 1, 2008; 82(21): 10776 - 10791. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lai, W.-Y. Tsai, S.-R. Lin, C.-L. Kao, H.-P. Hu, C.-C. King, H.-C. Wu, G.-J. Chang, and W.-K. Wang Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II J. Virol., July 1, 2008; 82(13): 6631 - 6643. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boonnak, B. M. Slike, T. H. Burgess, R. M. Mason, S.-J. Wu, P. Sun, K. Porter, I. F. Rudiman, D. Yuwono, P. Puthavathana, et al. Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection J. Virol., April 15, 2008; 82(8): 3939 - 3951. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. van der Schaar, M. J. Rust, B.-L. Waarts, H. van der Ende-Metselaar, R. J. Kuhn, J. Wilschut, X. Zhuang, and J. M. Smit Characterization of the Early Events in Dengue Virus Cell Entry by Biochemical Assays and Single-Virus Tracking J. Virol., November 1, 2007; 81(21): 12019 - 12028. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oliphant, G. E. Nybakken, M. Engle, Q. Xu, C. A. Nelson, S. Sukupolvi-Petty, A. Marri, B.-E. Lachmi, U. Olshevsky, D. H. Fremont, et al. Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein J. Virol., December 15, 2006; 80(24): 12149 - 12159. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |